Advanced life support ambulance transport increases mortality

Advanced care, increased risk

 

Boston, MA, USA (October 12, 2015) – Patients with trauma, stroke, heart attack and respiratory failure who were transported by basic life support (BLS) ambulances had a better chance of survival than patients who were transported by advanced life support (ALS) ambulances, a study of Medicare patients in urban counties nationwide found. 


"We studied conditions that were representative of the major causes of death where we thought we were most likely to see a benefit from the kinds of services that ALS provides," said Prachi Sanghavi, a visiting research fellow in health care policy at Harvard Medical School and assistant professor in the Department of Public Health Sciences in the Biological Sciences Division of the University of Chicago. "But what we found was that basic life support patients were more likely to survive and more likely to have better non-survival outcomes like neurological functioning."
The results are published in Annals of Internal Medicine.

 

Advanced life support ambulances are responsible for 65 percent of emergency care for Medicare patients in the United States and are dispatched preferentially for patients with life-threatening conditions.

 

The study analyzed outcomes for nearly 400,000 emergency patients from a 20 percent random sample of traditional Medicare beneficiaries from non-rural counties between 2006 and 2011. The research was conducted at Harvard Medical School with co-authors Anupam Jena, HMS associate professor of health care policy; Joseph Newhouse, John D. MacArthur Professor of Health Policy and Management at Harvard University; and Alan Zaslavsky, HMS professor of health care policy (statistics).

 

The researchers studied survival differences between patients who received advanced life support transport in counties that use more ALS ambulances and patients who received basic life support transport in counties that use less ALS ambulances. They found that patients with acute myocardial infarction (or heart attack) were 5.9 percent more likely to survive for 90 days after their ambulance transport if they were transported in a BLS rather than ALS ambulance.

 

Patients with stroke, who were transported in BLS ambulances, had a 4.3 percentage point greater chance of surviving for 90 days (with overall stroke survival in the sample at 71 percent), and BLS transported patients with critical major trauma had a 12.5 percentage point greater chance of surviving for 90 days than ALS transported patients with the same conditions.

Werbung

 

In addition to improved outcomes, greater use of BLS ambulances would also save money, the researchers said. Using 2011 reimbursement levels of advanced life support and basic life support transport, they found that Medicare would have spent $322 million less on ambulance services in 2011 if all ground emergency rides had been BLS.

 

"This study demonstrates that in medicine costlier isn’t always better; simply transporting the patient to the hospital as soon as possible appears to have a high payoff," Newhouse said.

 

Advanced life support ambulances, staffed by paramedics, are equipped to perform more invasive procedures than BLS ambulances, which are staffed by emergency medical technicians. Faced with a patient in respiratory distress, an ALS crew might intubate the patient; a BLS crew in the same situation would use a bag-mask respirator. The ALS approach–known as "stay and play"–takes longer to deliver patients to the hospital than the BLS "scoop and run" methodology.

 

There is scant evidence for the benefits of ALS transport, the researchers said, and some evidence that it is harmful to patients, including a study last year by the same team that showed better survival rates following BLS transport for patients with cardiac arrest.

 

The researchers used two distinct approaches to measuring the differences between ALS and BLS outcomes, in order to overcome any potential selection biases that might have been inherent in either model. Both approaches generally found that BLS patients for the studied conditions had better survival rates than ALS patients.

 

 

 

This research was supported by a National Science Foundation Graduate Research Fellowship, the Agency for Healthcare Research and Quality (1R36HS022798-01), and the Office of the Director, National Institutes of Health (NIH Early Independence Award, 1DP5OD017897-01).

 

Harvard Medical School has more than 7,500 full-time faculty working in 10 academic departments located at the School’s Boston campus or in hospital-based clinical departments at 15 Harvard-affiliated teaching hospitals and research institutes: Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Cambridge Health Alliance, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care Institute, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children’s Center, Mass. Eye and Ear/Schepens Eye Research Institute, Massachusetts General Hospital, McLean Hospital, Mount Auburn Hospital, Spaulding Rehabilitation Hospital and VA Boston Healthcare System.

 


 

Harvard Medical School, 12.10.2015 (tB).

MEDICAL NEWS

COVID-19 pandemic sees increased consults for alcohol-related GI and liver…
The eyes offer a window into Alzheimer’s disease
Ventilating the rectum to support respiration
Screening for ovarian cancer did not reduce deaths
Fatigue, mood disorders associated with post-COVID-19 syndrome

SCHMERZ PAINCARE

Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden
Deutscher Schmerz- und Palliativtag 2021 – ONLINE: Schmerzmediziner, Politiker und…
Deutscher Schmerz- und Palliativtag 2021 – ONLINE: COVID-19-Pandemie belastet Schmerzpatienten…

DIABETES

Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf
Risikofaktoren für einen schweren COVID-19-Verlauf bei Menschen mit Diabetes
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ meldet…

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Krebs – eine unterschätzte finanzielle Herausforderung
Cannabidiol gegen Hirntumore
Assistierte Selbsttötung bei Krebspatienten: Regelungsbedarf und Ermessensspielraum
Leberkrebs: Bei welchen Patienten wirkt die Immuntherapie?
Konferenzbericht vom virtuellen Münchener Fachpresse-Workshop Supportive Therapie in der Onkologie

MULTIPLE SKLEROSE

Neue S2k-Leitlinie für Diagnostik und Therapie der Multiplen Sklerose
Krankheitsbezogenes Kompetenznetz Multiple Sklerose: Stellungnahme zu SARS CoV 2 Impfdaten…
Schwangere mit MS: Schadet Schubbehandlung dem Ungeborenen?
Multiple Sklerose: Ein Sprung sagt mehr, als viele Kreuzchen auf…
Multiple Sklerose: Salzkonsum reguliert Autoimmunerkrankung

PARKINSON

Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung
Neuer Bewegungsratgeber unterstützt Menschen mit M. Parkinson durch Yoga
Covid-19-Prävention: besondere Vorsicht bei Patienten mit der Parkinson-Krankheit